PFIZER REPORTS THIRD-QUARTER 2021 RESULTS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/12/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Pfizer (PFE) Stock Rallies on Beat-and-Raise, Analysts Divided on How Shares Will React
November 2, 2021 8:44 AM EDTShares of Pfizer (NYSE: PFE) are trading over 3% higher in pre-open Tuesday after the company reported better-than-expected Q3 results and raised its FY guidance.
Pfizer reported EPS of $1.37 to easily beat the analyst estimate of $1.08. Revenue for the quarter came in at $24.1 billion versus the consensus estimate of $22.68 billion.
Dr. Albert Bourla, Chairman and Chief Executive Officer, stated: More than 75% of the revenues we have recorded up through third-quarter 2021 for Comirnaty(1) have come from... More
Pfizer (PFE) Tops Q3 EPS by 29c, Raises FY Guidance
November 2, 2021 6:48 AM EDTPfizer (NYSE: PFE) reported Q3 EPS of $1.37, $0.29 better than the analyst estimate of $1.08. Revenue for the quarter came in at $24.1 billion versus the consensus estimate of $22.68 billion.
GUIDANCE:
Pfizer sees 2021 EPS of $4.13-$4.18 (previously $3.95 to $4.05). Pfizer sees 2021 revenue of $81-82 billion (previously... More
